Trial Profile
Phase II Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2021
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Gimeracil/oteracil/tegafur; Paclitaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 24 Aug 2017 New trial record